Investigating the role of TET deficiency in promoting T cell expansion and inflammation
研究 TET 缺陷在促进 T 细胞扩增和炎症中的作用
基本信息
- 批准号:10522926
- 负责人:
- 金额:$ 54.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-06-07 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdoptive TransferAffectAgingAneuploidyArchitectureAutoimmuneAutoimmune DiseasesBiochemicalBone MarrowBone Marrow TransplantationCD4 Positive T LymphocytesCardiovascular DiseasesCell Culture SystemCell LineageCell physiologyCellsChimera organismChromosomal InstabilityChromosome 17CytosineDNADNA DamageDNA MethylationDNA Modification MethylasesDNA StructureDNA Transposable ElementsDataDevelopmentDioxygenasesDiseaseEnhancersEnterobacteria phage P1 Cre recombinaseEnzymesFOXP3 geneFemaleFunctional disorderG-QuartetsGenesGenomeHematopoiesisHematopoieticHematopoietic NeoplasmsHeterochromatinHistonesHumanImmuneImmunocompetentImpairmentIn VitroIndividualInfiltrationInflammationInflammatoryInterferon Type IInterferonsInterleukin-17Interleukin-6IronLinkLoxP-flanked alleleLymphocyteLysineMHC antigenMalignant NeoplasmsMethodsMethylationMolecularMouse StrainsMusMutant Strains MiceMutationMyelogenousNeurodegenerative DisordersOncogenicOrganOutcomeOxidesOxygenPaperPathway interactionsPatientsPenetrancePhenotypeProteinsRNARecurrenceRegulatory T-LymphocyteRepetitive SequenceReportingRoleSignal TransductionSolidSterilityStructureSyndromeSystemSystemic Lupus ErythematosusT-Cell ReceptorT-LymphocyteTestingTetanus Helper PeptideTrisomy 17Up-RegulationX ChromosomeX Inactivationalpha ketoglutaratecancer cellcell typechromosome missegregationcongeniccytokinedemethylationexperimental studyfightinggenome-wideimprovedin vivoinnate immune sensingmethyl groupmethylation patternorgan transplant rejectionpremalignantpreventpromoterresponsestemstem cellssystemic inflammatory responsewhole genome
项目摘要
Abstract
DNA cytosine methylation (hereafter, DNA methylation) has a critical role in cell lineage specification as well as
suppression of repetitive and transposable elements in the genome. DNA methyltransferases attach a methyl
group to generate 5-methylcytosine (5mC); TET methylcytosine dioxygenases cause DNA demethylation by
oxidizing the methyl group of 5mC to 5-hydroxymethylcytosine (5hmC) and beyond. We have shown that TET-
deficient cell types display not only the expected increase in DNA methylation at promoters and enhancers, but
also a paradoxical decrease in DNA methylation in heterochromatic regions of the genome. The consequences
of these molecular features remain to be understood, but similar alterations in genome-wide DNA methylation
patterns have been observed in cancer and aging.
By studying the phenotypes of several mouse strains in which Cre recombinase was expressed either inducibly
or developmentally in immune/ hematopoietic cell types, we showed that deletion of two or more Tet genes
skewed cell lineage commitment in the relevant cell type, in a manner that correlated with changes in cell lineage
commitment. More striking phenotypes, however, were that Tet2/3 fl/fl CD4Cre mice displayed massive TCR-
dependent expansion of iNKT cells; and that Tet2/3 fl/fl Foxp3Cre mice developed a dominant proinflammatory
phenotype observed in heterozygous female mice, in mixed bone marrow chimaeras, and in immunocompetent
recipients injected with total CD4+ T cells from Tet2/3 fl/fl Foxp3Cre mice. This phenotype differs markedly from
that observed in heterozygous Foxp3+/- females and in immunocompetent mice injected with Foxp3-deficient
cells, which do not develop disease. In Aim 1, we will address the mechanisms underlying the striking expansion
of Tet2/3-deficient iNKT cells by using adoptive transfer approaches in vivo and recently-developed cell culture
systems that recapitulate the expansion in vitro. In Aim 2, we will ask whether the dominant autoimmune/
inflammatory phenotype of Tet2/3-deficient T regulatory cells requires, directly or indirectly, the decreased DNA
methylation in heterochromatin observed in every TET-deficient cell type examined so far. Decreased DNA
methylation in heterochromatin results in “heterochromatin dysfunction”, an aberrant cellular condition linked to
autoimmune/ inflammatory disorders, cancer, aging, and neurodegenerative diseases, that stems from aberrant
expression of transposable elements (TEs) and resulting DNA damage. DNA damage provokes “sterile
inflammation”: activation of innate immune sensing pathways for RNA and DNA with consequent upregulation
of type I interferons, interferon-induced genes and proinflammatory cytokines (e.g. IL-1b, IL-6, IFNg, IL-17)
Our proposed experiments will add to our knowledge of how TET proteins influence T cell expansion and T
regulatory function. More broadly, they will enhance our general understanding of the links connecting TET
deficiency and TE expression with autoimmune/ inflammatory diseases, clonal hematopoiesis, a premalignant
syndrome of older individuals associated with inflammation and cardiovascular disease, and cancer.
抽象的
DNA 胞嘧啶甲基化(以下简称 DNA 甲基化)在细胞谱系规范以及
抑制基因组中的重复和转座元件。
产生 5-甲基胞嘧啶 (5mC) 的 TET 甲基胞嘧啶双加氧酶导致 DNA 去甲基化;
将 5mC 的甲基氧化为 5-羟甲基胞嘧啶 (5hmC) 及以上 我们已经证明 TET-。
缺陷细胞类型不仅显示出启动子和增强子处 DNA 甲基化的预期增加,而且
基因组异染色质区域 DNA 甲基化也出现矛盾的减少。
这些分子特征的具体情况仍有待了解,但全基因组 DNA 甲基化也发生了类似的变化
在癌症和衰老中观察到了模式。
通过研究几种诱导表达 Cre 重组酶的小鼠品系的表型
或者在免疫/造血细胞类型的发育过程中,我们发现两个或多个 Tet 基因的缺失
相关细胞类型中细胞谱系的倾斜,其方式与细胞谱系的变化相关
然而,更引人注目的表型是 Tet2/3 fl/fl CD4Cre 小鼠表现出大量的 TCR-。
iNKT 细胞的依赖性扩增;Tet2/3 fl/fl Foxp3Cre 小鼠产生显性促炎性
在杂合雌性小鼠、混合骨髓嵌合体和免疫功能正常的小鼠中观察到的表型
注射来自 Tet2/3 fl/fl Foxp3Cre 小鼠的总 CD4+ T 细胞的受者这种表型与此显着不同。
在杂合 Foxp3+/- 雌性小鼠和注射 Foxp3 缺陷的免疫功能小鼠中观察到的结果
在目标 1 中,我们将探讨这种显着扩增的机制。
通过使用体内过继转移方法和最近开发的细胞培养来培养 Tet2/3 缺陷的 iNKT 细胞
在目标 2 中,我们将询问是否主要的自身免疫/
Tet2/3 缺陷型 T 调节细胞的炎症表型直接或间接需要 DNA 减少
迄今为止,在每种 TET 缺陷细胞类型中均观察到异染色质甲基化 DNA 减少。
异染色质甲基化导致“异染色质功能障碍”,这是一种与以下因素相关的异常细胞状况
源自异常的自身免疫/炎症性疾病、癌症、衰老和神经退行性疾病
转座元件 (TE) 的表达以及由此产生的 DNA 损伤。
炎症”:激活 RNA 和 DNA 的先天免疫传感通路,从而导致上调
I 型干扰素、干扰素诱导基因和促炎细胞因子(例如 IL-1b、IL-6、IFNg、IL-17)
我们提出的实验将增加我们对 TET 蛋白如何影响 T 细胞扩增和 T 细胞的了解。
更广泛地说,它们将增强我们对连接 TET 的联系的总体理解。
自身免疫/炎症性疾病、克隆造血、癌前病变的缺乏和 TE 表达
与炎症、心血管疾病和癌症相关的老年人综合症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anjana Rao其他文献
Anjana Rao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anjana Rao', 18)}}的其他基金
Exploring the potential of TET inhibition in cancer immunotherapy
探索 TET 抑制在癌症免疫治疗中的潜力
- 批准号:
10202515 - 财政年份:2020
- 资助金额:
$ 54.9万 - 项目类别:
Exploring the potential of TET inhibition in cancer immunotherapy
探索 TET 抑制在癌症免疫治疗中的潜力
- 批准号:
10819075 - 财政年份:2020
- 资助金额:
$ 54.9万 - 项目类别:
Exploring the potential of TET inhibition in cancer immunotherapy
探索 TET 抑制在癌症免疫治疗中的潜力
- 批准号:
10665608 - 财政年份:2020
- 资助金额:
$ 54.9万 - 项目类别:
Exploring the potential of TET inhibition in cancer immunotherapy
探索 TET 抑制在癌症免疫治疗中的潜力
- 批准号:
10441261 - 财政年份:2020
- 资助金额:
$ 54.9万 - 项目类别:
Investigating the role of TET deficiency in promoting T cell expansion and inflammation
研究 TET 缺陷在促进 T 细胞扩增和炎症中的作用
- 批准号:
10640187 - 财政年份:2017
- 资助金额:
$ 54.9万 - 项目类别:
Epigenetic control of Foxp3 expression in induced T regulatory cells
诱导 T 调节细胞中 Foxp3 表达的表观遗传控制
- 批准号:
10166759 - 财政年份:2017
- 资助金额:
$ 54.9万 - 项目类别:
TET enzymes as guardians of genome stability
TET 酶作为基因组稳定性的守护者
- 批准号:
9761480 - 财政年份:2016
- 资助金额:
$ 54.9万 - 项目类别:
TET enzymes as guardians of genome stability
TET 酶作为基因组稳定性的守护者
- 批准号:
9342700 - 财政年份:2016
- 资助金额:
$ 54.9万 - 项目类别:
TET enzymes as guardians of genome stability
TET 酶作为基因组稳定性的守护者
- 批准号:
10246473 - 财政年份:2016
- 资助金额:
$ 54.9万 - 项目类别:
TET enzymes as guardians of genome stability
TET 酶作为基因组稳定性的守护者
- 批准号:
10477020 - 财政年份:2016
- 资助金额:
$ 54.9万 - 项目类别:
相似海外基金
Pathogenic T cells in discoid lupus erythematosus
盘状红斑狼疮中的致病性 T 细胞
- 批准号:
10664134 - 财政年份:2023
- 资助金额:
$ 54.9万 - 项目类别:
Tyk2 and Associated Cytokines in Salivary Gland Autoimmunity
Tyk2 和唾液腺自身免疫中的相关细胞因子
- 批准号:
10733367 - 财政年份:2023
- 资助金额:
$ 54.9万 - 项目类别:
Development of an Effective Strategy to Block Nab Activity for AAV Brain Transduction
开发一种有效策略来阻断 AAV 脑转导的 Nab 活性
- 批准号:
10600969 - 财政年份:2023
- 资助金额:
$ 54.9万 - 项目类别:
Spatial genomic tools to interrogate T cell clonotypes, tumor clones and the microenvironment
用于询问 T 细胞克隆型、肿瘤克隆和微环境的空间基因组工具
- 批准号:
10565141 - 财政年份:2023
- 资助金额:
$ 54.9万 - 项目类别:
Gut Metabolites, T cells, and Salt-Sensitive Hypertension
肠道代谢物、T 细胞和盐敏感性高血压
- 批准号:
10568068 - 财政年份:2023
- 资助金额:
$ 54.9万 - 项目类别: